People: Washington Professor Elected To Oversee Dermatology Foundation Grant Committee

Karen A. Holbrook, a professor of biological structure at the University of Washington School of Medicine in Seattle, has been elected by the Dermatology Foundation to chair its medical and scientific committee. Holbrook's primary role as new chairwoman will be to lead the Evanston, Ill., organization's grant application review process for basic research. The 16-member committee, which will oversee the foundation's 1992 Career Development awards, fellowships, and grants program, will have its f

Written byRon Kaufman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Karen A. Holbrook, a professor of biological structure at the University of Washington School of Medicine in Seattle, has been elected by the Dermatology Foundation to chair its medical and scientific committee. Holbrook's primary role as new chairwoman will be to lead the Evanston, Ill., organization's grant application review process for basic research.

The 16-member committee, which will oversee the foundation's 1992 Career Development awards, fellowships, and grants program, will have its first meeting in December. In its 25 years of existence, this awards program has collected more than $7 million to assist dermatologic research in the United States. This year, Holbrook says, she expects well over 100 grant applications.

Holbrook describes her organization as the major granting institution in the United States for dermatologic studies. "I think this is the major [program], besides the federal funding agencies, to give new investigators a good start in academic medicine and biomedical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies